BioSpace News Archive

Merger combines more than 30 years of patient-centered expertise to Empower Everyone, Ignore No One

Partnership to focus on Alzheimer’s disease, breast cancer, diabetes, obesity

United Therapeutics Corporation announced that the BEAT clinical study of esuberaprost tablets in patients suffering from pulmonary arterial hypertension did not meet its primary endpoint of delayed time to first clinical worsening event.

Axonics Modulation Technologies, Inc. announced that Nancy L. Snyderman, M.D. and Jane E. Kiernan have been appointed to the Axonics board of directors, effective immediately.

Medivir AB announces that the Annual Report for 2018 now is available at the company’s website: www.medivir.com.

Asepticys LLC, a leading innovator and developer of anti-infective pharmaceutical and consumer healthcare products, today announced the successful completion of multi-site human clinical trials for Asepticys’ novel contact lens care solution containing TriFlect™ technology, and the submission of its 510k application to the U.S. Food and Drug Administration.

ACell, Inc. announced that it has entered into an exclusive long-term product supply and distribution agreement with First Horizon, LLC and Weihai Jierui Medical Products Co., Ltd.

BD BACTEC™ Platelet Quality Control Media is cleared by the U.S. Food and Drug Administration and CE-IVD marked for platelet testing

Ascentage Pharma announced that it has entered into a strategic collaboration with Shanghai Junshi Biosciences Co., Ltd. to explore the synergies of Ascentage’s Inhibitor of Apoptosis Proteins (IAP) inhibitor APG-1387, and Junshi Biosciences’ anti-PD-1 therapy toripalimab in clinical trials in solid and hematological tumors in China.

Homogeneous 25.9 Tesla Standard-bore NMR Magnet Sets New World Record